{"id":"https://openalex.org/W2116589370","doi":"https://doi.org/10.2337/diacare.27.6.1358","title":"Atorvastatin Decreases Apolipoprotein C-III in Apolipoprotein B-Containing Lipoprotein and HDL in Type 2 Diabetes","display_name":"Atorvastatin Decreases Apolipoprotein C-III in Apolipoprotein B-Containing Lipoprotein and HDL in Type 2 Diabetes","publication_year":2004,"publication_date":"2004-06-01","ids":{"openalex":"https://openalex.org/W2116589370","doi":"https://doi.org/10.2337/diacare.27.6.1358","mag":"2116589370","pmid":"https://pubmed.ncbi.nlm.nih.gov/15161788"},"language":"en","primary_location":{"id":"doi:10.2337/diacare.27.6.1358","doi":"https://doi.org/10.2337/diacare.27.6.1358","is_oa":true,"landing_page_url":"https://doi.org/10.2337/diacare.27.6.1358","pdf_url":"https://diabetesjournals.org/care/article-pdf/27/6/1358/645927/zdc00604001358.pdf","source":{"id":"https://openalex.org/S49878492","display_name":"Diabetes Care","issn_l":"0149-5992","issn":["0149-5992","1935-5548"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320274","host_organization_name":"American Diabetes Association","host_organization_lineage":["https://openalex.org/P4310320274"],"host_organization_lineage_names":["American Diabetes Association"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes Care","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://diabetesjournals.org/care/article-pdf/27/6/1358/645927/zdc00604001358.pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5060583173","display_name":"Geesje M. Dallinga\u2010Thie","orcid":"https://orcid.org/0000-0001-5412-5923","observed_orcids":["https://orcid.org/0000-0001-5412-5923"]},"institutions":[{"id":"https://openalex.org/I3018483916","display_name":"University Medical Center Utrecht","ror":"https://ror.org/0575yy874","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I3018483916"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Geesje M. Dallinga-Thie","raw_affiliation_strings":["Department of Internal Medicine, University Medical Center Utrecht, Utrecht, the Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Internal Medicine, University Medical Center Utrecht, Utrecht, the Netherlands","institution_ids":["https://openalex.org/I3018483916"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019178144","display_name":"Ingrid I.L. Berk-Planken","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2801952686","display_name":"Erasmus MC","ror":"https://ror.org/018906e22","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2801952686"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Ingrid I.L. Berk-Planken","raw_affiliation_strings":["Department of Internal Medicine, Erasmus Medical Center, Rotterdam, the Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Internal Medicine, Erasmus Medical Center, Rotterdam, the Netherlands","institution_ids":["https://openalex.org/I2801952686"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110027409","display_name":"Aart H. Bootsma","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2801952686","display_name":"Erasmus MC","ror":"https://ror.org/018906e22","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2801952686"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Aart H. Bootsma","raw_affiliation_strings":["Department of Internal Medicine, Erasmus Medical Center, Rotterdam, the Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Internal Medicine, Erasmus Medical Center, Rotterdam, the Netherlands","institution_ids":["https://openalex.org/I2801952686"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025432204","display_name":"Hans Jansen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2801952686","display_name":"Erasmus MC","ror":"https://ror.org/018906e22","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2801952686"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Hans Jansen","raw_affiliation_strings":["Department of Biochemistry, Erasmus Medical Center, Rotterdam, the Netherlands","Department of Clinical Chemistry, Erasmus Medical Center, Rotterdam, the Netherlands","Department of Internal Medicine, Erasmus Medical Center, Rotterdam, the Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Biochemistry, Erasmus Medical Center, Rotterdam, the Netherlands","institution_ids":["https://openalex.org/I2801952686"]},{"raw_affiliation_string":"Department of Clinical Chemistry, Erasmus Medical Center, Rotterdam, the Netherlands","institution_ids":["https://openalex.org/I2801952686"]},{"raw_affiliation_string":"Department of Internal Medicine, Erasmus Medical Center, Rotterdam, the Netherlands","institution_ids":["https://openalex.org/I2801952686"]}]},{"author_position":"last","author":{"id":null,"display_name":"on behalf of the Diabetes Atorvastatin Lipid Intervention (DALI) Study Group","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"on behalf of the Diabetes Atorvastatin Lipid Intervention (DALI) Study Group","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":1.4502,"has_fulltext":true,"cited_by_count":51,"citation_normalized_percentile":{"value":0.84176214,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":98},"biblio":{"volume":"27","issue":"6","first_page":"1358","last_page":"1364"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10394","display_name":"Lipoproteins and Cardiovascular Health","score":0.9707000255584717,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10394","display_name":"Lipoproteins and Cardiovascular Health","score":0.9707000255584717,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T13430","display_name":"Lipid metabolism and disorders","score":0.0272000003606081,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10027","display_name":"Diabetes, Cardiovascular Risks, and Lipoproteins","score":0.0012000000569969416,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/atorvastatin","display_name":"atorvastatin","score":0.9509999752044678},{"id":"https://openalex.org/keywords/apolipoprotein-c-iii","display_name":"apolipoprotein C-III","score":0.9990000128746033},{"id":"https://openalex.org/keywords/apolipoprotein-b-containing-lipoproteins","display_name":"apolipoprotein B-containing lipoproteins","score":0.9240000247955322},{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.9340000152587891},{"id":"https://openalex.org/keywords/hypertriglyceridemia","display_name":"hypertriglyceridemia","score":0.9520000219345093},{"id":"https://openalex.org/keywords/triglyceride-rich-lipoproteins","display_name":"triglyceride-rich lipoproteins","score":0.8709999918937683},{"id":"https://openalex.org/keywords/lipoprotein-lipase","display_name":"lipoprotein lipase","score":0.9330000281333923},{"id":"https://openalex.org/keywords/cardiovascular-risk","display_name":"cardiovascular risk","score":0.5299999713897705},{"id":"https://openalex.org/keywords/statin-therapy","display_name":"statin therapy","score":0.6100000143051147},{"id":"https://openalex.org/keywords/hdl-cholesterol","display_name":"HDL cholesterol","score":0.6510000228881836}],"concepts":[{"id":"https://openalex.org/C2777482532","wikidata":"https://www.wikidata.org/wiki/Q668093","display_name":"Atorvastatin","level":2,"score":0.9219648838043213},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.8622066974639893},{"id":"https://openalex.org/C62746215","wikidata":"https://www.wikidata.org/wiki/Q14890615","display_name":"Apolipoprotein B","level":3,"score":0.7985068559646606},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.787743091583252},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5627726316452026},{"id":"https://openalex.org/C2778913445","wikidata":"https://www.wikidata.org/wiki/Q186319","display_name":"Triglyceride","level":3,"score":0.5443844199180603},{"id":"https://openalex.org/C94879076","wikidata":"https://www.wikidata.org/wiki/Q420014","display_name":"Lipoprotein lipase","level":3,"score":0.5426914691925049},{"id":"https://openalex.org/C2780072125","wikidata":"https://www.wikidata.org/wiki/Q28350","display_name":"Lipoprotein","level":3,"score":0.4888977110385895},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.4818792939186096},{"id":"https://openalex.org/C2778163477","wikidata":"https://www.wikidata.org/wiki/Q43656","display_name":"Cholesterol","level":2,"score":0.461748868227005},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.4059479236602783},{"id":"https://openalex.org/C171089720","wikidata":"https://www.wikidata.org/wiki/Q193583","display_name":"Adipose tissue","level":2,"score":0.05921453237533569}],"mesh":[{"descriptor_ui":"D000069059","descriptor_name":"Atorvastatin","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000806","descriptor_name":"Angiotensin-Converting Enzyme Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D001055","descriptor_name":"Apolipoproteins B","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":true},{"descriptor_ui":"D001056","descriptor_name":"Apolipoproteins C","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":true},{"descriptor_ui":"D001056","descriptor_name":"Apolipoproteins C","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":true},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006538","descriptor_name":"Heptanoic Acids","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008075","descriptor_name":"Lipoproteins, HDL","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":true},{"descriptor_ui":"D008075","descriptor_name":"Lipoproteins, HDL","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011758","descriptor_name":"Pyrroles","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D014280","descriptor_name":"Triglycerides","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D015228","descriptor_name":"Hypertriglyceridemia","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D015228","descriptor_name":"Hypertriglyceridemia","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":true},{"descriptor_ui":"D053305","descriptor_name":"Apolipoprotein C-III","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":6,"locations":[{"id":"doi:10.2337/diacare.27.6.1358","doi":"https://doi.org/10.2337/diacare.27.6.1358","is_oa":true,"landing_page_url":"https://doi.org/10.2337/diacare.27.6.1358","pdf_url":"https://diabetesjournals.org/care/article-pdf/27/6/1358/645927/zdc00604001358.pdf","source":{"id":"https://openalex.org/S49878492","display_name":"Diabetes Care","issn_l":"0149-5992","issn":["0149-5992","1935-5548"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320274","host_organization_name":"American Diabetes Association","host_organization_lineage":["https://openalex.org/P4310320274"],"host_organization_lineage_names":["American Diabetes Association"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes Care","raw_type":"journal-article"},{"id":"pmid:15161788","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/15161788","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes care","raw_type":"Clinical Trial"},{"id":"pmh:amcpub:oai:pure.amc.nl:publications/aef8cccb-46f4-4d4f-88f5-9f660312e904","doi":null,"is_oa":false,"landing_page_url":"https://pure.amc.nl/en/publications/atorvastatin-decreases-apolipoprotein-ciii-in-apolipoprotein-bcontaining-lipoprotein-and-hdl-in-type-2-diabetes-a-potential-mechanism-to-lower-plasma-triglycerides(aef8cccb-46f4-4d4f-88f5-9f660312e904).html","pdf_url":null,"source":{"id":"https://openalex.org/S4306401843","display_name":"Data Archiving and Networked Services (DANS)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1322597698","host_organization_name":"Royal Netherlands Academy of Arts and Sciences","host_organization_lineage":["https://openalex.org/I1322597698"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Diabetes care, 27(6), 1358 - 1364. American Diabetes Association Inc.","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:eur:oai:pure.eur.nl:publications/1c6f02e6-f523-47b7-8a33-d226dba60129","doi":null,"is_oa":false,"landing_page_url":"https://pure.eur.nl/en/publications/1c6f02e6-f523-47b7-8a33-d226dba60129","pdf_url":null,"source":{"id":"https://openalex.org/S4306401266","display_name":"EUR Research Repository (Erasmus University Rotterdam)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I913958620","host_organization_name":"Erasmus University Rotterdam","host_organization_lineage":["https://openalex.org/I913958620"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Diabetes Care, 27, 1358 - 1364. American Diabetes Association Inc.","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:pure.amsterdamumc.nl:openaire_cris_publications/37caa7eb-6457-4287-988c-8f5c37873782","doi":null,"is_oa":false,"landing_page_url":"https://pure.amsterdamumc.nl/en/publications/37caa7eb-6457-4287-988c-8f5c37873782","pdf_url":null,"source":{"id":"https://openalex.org/S7407055222","display_name":"Pure Amsterdam UMC","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Dallinga-Thie, G M, Berk-Planken, I I L, Bootsma, A H & Jansen, H 2004, 'Atorvastatin decreases apolipoprotein C-III in apolipoprotein B-containing lipoprotein and HDL in type 2 diabetes: a potential mechanism to lower plasma triglycerides', Diabetes care, vol. 27, no. 6, pp. 1358-1364. https://doi.org/10.2337/diacare.27.6.1358","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:pure.eur.nl:openaire_cris_publications/1c6f02e6-f523-47b7-8a33-d226dba60129","doi":null,"is_oa":false,"landing_page_url":"https://pure.eur.nl/en/publications/1c6f02e6-f523-47b7-8a33-d226dba60129","pdf_url":null,"source":{"id":"https://openalex.org/S4306401266","display_name":"EUR Research Repository (Erasmus University Rotterdam)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I913958620","host_organization_name":"Erasmus University Rotterdam","host_organization_lineage":["https://openalex.org/I913958620"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Dallinga-Thie, GM, Berk-Planken, I, Bootsma, AH & Jansen, H 2004, 'Diabetes Atorvastatin Lipid intervention (DALI) Study Group. Atorvastatin decreases apolipoprotein C-III in apolipoprotein B-containing lipoprotein and HDL in type 2 diabetes: a potential mechanism to lower plasma triglycerides', Diabetes Care, vol. 27, pp. 1358-1364.","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":{"id":"doi:10.2337/diacare.27.6.1358","doi":"https://doi.org/10.2337/diacare.27.6.1358","is_oa":true,"landing_page_url":"https://doi.org/10.2337/diacare.27.6.1358","pdf_url":"https://diabetesjournals.org/care/article-pdf/27/6/1358/645927/zdc00604001358.pdf","source":{"id":"https://openalex.org/S49878492","display_name":"Diabetes Care","issn_l":"0149-5992","issn":["0149-5992","1935-5548"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320274","host_organization_name":"American Diabetes Association","host_organization_lineage":["https://openalex.org/P4310320274"],"host_organization_lineage_names":["American Diabetes Association"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes Care","raw_type":"journal-article"},"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Randomized Controlled Trial","id":"https://openalex.org/study-designs/randomized-controlled-trial"},{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320307765","display_name":"Pfizer","ror":"https://ror.org/01xdqrp08"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2116589370.pdf","grobid_xml":"https://content.openalex.org/works/W2116589370.grobid-xml"},"referenced_works_count":48,"referenced_works":["https://openalex.org/W58112070","https://openalex.org/W1479910813","https://openalex.org/W1527680278","https://openalex.org/W1852408023","https://openalex.org/W1889257304","https://openalex.org/W1900613292","https://openalex.org/W1921210832","https://openalex.org/W1963872182","https://openalex.org/W1966084594","https://openalex.org/W1966628044","https://openalex.org/W2007225442","https://openalex.org/W2007233632","https://openalex.org/W2007730040","https://openalex.org/W2007835979","https://openalex.org/W2008276973","https://openalex.org/W2009144098","https://openalex.org/W2015776407","https://openalex.org/W2020885344","https://openalex.org/W2022158649","https://openalex.org/W2033886436","https://openalex.org/W2034051743","https://openalex.org/W2036674202","https://openalex.org/W2047070188","https://openalex.org/W2049546598","https://openalex.org/W2053373180","https://openalex.org/W2057271976","https://openalex.org/W2068012160","https://openalex.org/W2077247955","https://openalex.org/W2091016673","https://openalex.org/W2092138949","https://openalex.org/W2116404316","https://openalex.org/W2117306959","https://openalex.org/W2135865397","https://openalex.org/W2142371147","https://openalex.org/W2143340286","https://openalex.org/W2149677053","https://openalex.org/W2152316341","https://openalex.org/W2160942744","https://openalex.org/W2164468903","https://openalex.org/W2169911638","https://openalex.org/W2170750385","https://openalex.org/W2335398866","https://openalex.org/W2345903479","https://openalex.org/W2355582620","https://openalex.org/W2407262860","https://openalex.org/W2467846002","https://openalex.org/W2565229519","https://openalex.org/W2766011391"],"related_works":["https://openalex.org/W6990365022","https://openalex.org/W4255929069","https://openalex.org/W1979617647","https://openalex.org/W2111895850","https://openalex.org/W2025896258","https://openalex.org/W2565229519","https://openalex.org/W4230441687","https://openalex.org/W2060049429","https://openalex.org/W1966084594","https://openalex.org/W2163904462"],"abstract_inverted_index":{"OBJECTIVE:":[0],"Apolipoprotein":[1],"(apo)C-III":[2],"is":[3,46],"a":[4,89,200,224,236,262,283],"constituent":[5],"of":[6,11,19,25,28,58,74,113,241,288,299],"HDL":[7,64,117,165,228,232,244,269],"(HDL":[8],"apoC-III)":[9],"and":[10,34,63,80,101,107,119,128,150,161,171,175,181,210,231,250,271,291],"apoB-containing":[12],"lipoproteins":[13,21],"(LpB:C-III).":[14],"It":[15],"slows":[16],"the":[17,26,29,56,72,227,239,296],"clearance":[18],"triglyceride-rich":[20],"(TRLs)":[22],"by":[23,35],"inhibition":[24],"activity":[27],"enzyme":[30],"lipoprotein":[31,38],"lipase":[32],"(LPL)":[33],"interference":[36],"with":[37,78,97,139,199,276],"binding":[39],"to":[40,223],"cell-surface":[41],"receptors.":[42],"Elevated":[43],"plasma":[44,61,85,103,115,140,155,192,267],"LpB:C-III":[45,62,120,176,272],"an":[47],"independent":[48],"risk":[49],"factor":[50],"for":[51],"cardiovascular":[52],"disease.":[53],"We":[54,70],"studied":[55,71],"effect":[57,73,287,298],"atorvastatin":[59,83],"on":[60,84],"apoC-III.":[65],"RESEARCH":[66],"DESIGN":[67],"AND":[68],"METHODS:":[69],"30":[75],"weeks'":[76],"treatment":[77,152,220,259,290],"10":[79,158,168,178,205,247],"80":[81,162,172,182,211,251],"mg":[82],"apoC-III":[86,135,156,166,242],"levels":[87,112,273],"in":[88,191,195,202,226,238,261,266,274],"randomized,":[90],"double-blind,":[91],"placebo-controlled":[92],"trial":[93],"involving":[94],"217":[95],"patients":[96,275],"type":[98,277],"2":[99,278],"diabetes":[100],"fasting":[102],"triglycerides":[104,141,203],"between":[105],"1.5":[106],"6.0":[108],"mmol/l.":[109],"RESULTS:":[110],"Baseline":[111],"total":[114],"apoC-III,":[116,118,193,268,270],"were":[121],"41.5":[122],"+/-":[123,126,130],"10.0,":[124],"17.7":[125],"5.5,":[127],"23.8":[129],"7.7":[131],"mg/l,":[132],"respectively.":[133],"Plasma":[134],"was":[136],"strongly":[137,197],"correlated":[138,198],"(r":[142],"=":[143,208,214],"0.74,":[144],"P":[145,186,216,254],"<":[146,187,217,255],"0.001).":[147,188,218,256],"Atorvastatin":[148,219,258],"10-":[149],"80-mg":[151],"significantly":[153],"decreased":[154],"(atorvastatin":[157,167,177,204,246],"mg,":[159,163,169,173,179,183,206,212,248,252],"21%,":[160],"27%),":[164],"22%,":[170],"28%)":[174],"23%,":[180],"28%;":[184],"all":[185],"The":[189],"decrease":[190,201],"mainly":[194],"LpB:C-III,":[196],"r":[207,213],"0.70,":[209],"0.78;":[215],"also":[221],"leads":[222],"reduction":[225,265],"apoC-III-to-HDL":[229],"cholesterol":[230],"apoC-III-to-apoA-I":[233],"ratios,":[234],"indicating":[235],"change":[237],"number":[240],"per":[243],"particle":[245],"-21%,":[249],"-31%;":[253],"CONCLUSIONS:":[257],"resulted":[260],"significant":[263],"dose-dependent":[264],"diabetes.":[279],"These":[280],"data":[281],"indicate":[282],"potentially":[284],"important":[285],"antiatherogenic":[286],"statin":[289],"may":[292],"explain":[293],"(part":[294],"of)":[295],"triglyceride-lowering":[297],"atorvastatin.":[300]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":1},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":3},{"year":2018,"cited_by_count":4},{"year":2017,"cited_by_count":3},{"year":2016,"cited_by_count":4},{"year":2015,"cited_by_count":4},{"year":2013,"cited_by_count":1},{"year":2012,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}